|
OMIM |
Link |
Information gain |
01 |
|
myoclonic epilepsy, juvenile, 3
|
[NCBI]
|
0.00235325
|
|
|
CFB
|
[NCBI]
|
0.00124302
|
|
|
SLE
|
[NCBI]
|
0.000388231
|
|
|
complement component 2 deficiency
|
[NCBI]
|
0.0001397
|
|
|
PLT1
|
[NCBI]
|
0.000119088
|
|
|
CFD
|
[NCBI]
|
9.70852e-05
|
|
|
CFH
|
[NCBI]
|
8.27851e-05
|
|
|
RA
|
[NCBI]
|
8.14208e-05
|
|
|
complement factor h deficiency
|
[NCBI]
|
7.48633e-05
|
|
|
SCA17
|
[NCBI]
|
7.36147e-05
|
|
|
C4A
|
[NCBI]
|
7.25005e-05
|
|
|
NRCLP1
|
[NCBI]
|
6.47417e-05
|
|
|
PGM3
|
[NCBI]
|
5.39343e-05
|
|
|
SCA1
|
[NCBI]
|
4.53211e-05
|
|
|
C4B
|
[NCBI]
|
4.40432e-05
|
|
|
C3
|
[NCBI]
|
4.16691e-05
|
|
|
FMF
|
[NCBI]
|
4.13688e-05
|
|
|
MBL2
|
[NCBI]
|
4.10771e-05
|
|
|
HLA-A
|
[NCBI]
|
3.72493e-05
|
|
|
DOM3Z
|
[NCBI]
|
3.69016e-05
|
|
|
SKIV2L
|
[NCBI]
|
3.09311e-05
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
2.90131e-05
|
|
|
ITGAM
|
[NCBI]
|
2.89588e-05
|
|
|
CR2
|
[NCBI]
|
2.63929e-05
|
|
|
C4BPA
|
[NCBI]
|
2.4313e-05
|
|
|
HLA-DPA1
|
[NCBI]
|
2.39795e-05
|
|
|
HLA-G
|
[NCBI]
|
2.25685e-05
|
|
|
CR1
|
[NCBI]
|
2.23263e-05
|
|
|
HLA-DRA
|
[NCBI]
|
1.87038e-05
|
|
|
HP
|
[NCBI]
|
1.86663e-05
|
|
|
IL2RA
|
[NCBI]
|
1.81403e-05
|
|
|
PGM1
|
[NCBI]
|
1.75358e-05
|
|
|
KLF4
|
[NCBI]
|
1.72579e-05
|
|
|
HRG
|
[NCBI]
|
1.47385e-05
|
|
|
CF
|
[NCBI]
|
1.39716e-05
|
|
|
UCP1
|
[NCBI]
|
1.2461e-05
|
|
|
GC
|
[NCBI]
|
1.20882e-05
|
|
|
IL6
|
[NCBI]
|
1.12499e-05
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
8.22229e-06
|
|
|
EGF
|
[NCBI]
|
4.5305e-06
|
|
|
TNF
|
[NCBI]
|
3.74178e-06
|
|
|
AFP
|
[NCBI]
|
2.76181e-07
|
|
|
MG
|
[NCBI]
|
3.55074e-08
|
|